Accentuating the Positive: Do Trials Give Unrealistic Expectations of Long-Term Survival?
作者信息
Kiely Belinda E, Stockler Martin R
机构信息
NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.
Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW, Australia.
出版信息
JNCI Cancer Spectr. 2019 Apr 15;3(2):pkz018. doi: 10.1093/jncics/pkz018. eCollection 2019 Jun.
Abstract
摘要
相似文献
1
Accentuating the Positive: Do Trials Give Unrealistic Expectations of Long-Term Survival?强调积极方面：试验是否会让人对长期生存产生不切实际的期望？
JNCI Cancer Spectr. 2019 Apr 15;3(2):pkz018. doi: 10.1093/jncics/pkz018. eCollection 2019 Jun.
2
Dispositional optimism and therapeutic expectations in early-phase oncology trials.早期肿瘤学试验中的性格乐观与治疗期望
Cancer. 2016 Apr 15;122(8):1238-46. doi: 10.1002/cncr.29908. Epub 2016 Feb 16.
3
Effects of exposure to unrealistic promises about dieting: are unrealistic expectations about dieting inspirational?
Int J Eat Disord. 2005 Mar;37(2):142-9. doi: 10.1002/eat.20071.
4
Satisfaction With Expectations-Based Education in Women Undergoing Breast Reconstruction.基于期望的教育在接受乳房重建的女性中的满意度。
Plast Surg Nurs. 2021;41(2):71-84. doi: 10.1097/PSN.0000000000000369.
5
Satisfaction With Expectations-Based Education in Women Undergoing Breast Reconstruction.基于期望的教育在接受乳房重建的女性中的满意度。
Plast Surg Nurs. 2021;41(4):211-224. doi: 10.1097/PSN.0000000000000408.
6
The Presence and Persistence of Unrealistic Expectations in Patients Undergoing Nerve Surgery.神经外科手术患者不切实际期望的存在和持续。
Neurosurgery. 2020 Jun 1;86(6):778-782. doi: 10.1093/neuros/nyz335.
7
Pain expectations in neuropathic pain: Is it best to be optimistic?神经病理性疼痛中的疼痛预期：保持乐观是最佳选择吗？
Eur J Pain. 2017 Apr;21(4):605-613. doi: 10.1002/ejp.962. Epub 2016 Oct 14.
8
Perceptions of control and unrealistic optimism in early-phase cancer trials.早期癌症试验中的控制感和不切实际的乐观主义。
J Med Ethics. 2018 Feb;44(2):121-127. doi: 10.1136/medethics-2016-103724. Epub 2017 Aug 3.
9
Expectations of outcomes in patients with colorectal cancer.结直肠癌患者对治疗结果的期望。
BJS Open. 2018 May 10;2(5):285-292. doi: 10.1002/bjs5.73. eCollection 2018 Sep.
10
Concurrently examining unrealistic absolute and comparative optimism: Temporal shifts, individual-difference and event-specific correlates, and behavioural outcomes.同时考察不切实际的绝对乐观和比较乐观：时间变化、个体差异和特定事件的相关因素以及行为结果。
Br J Psychol. 2017 Feb;108(1):107-126. doi: 10.1111/bjop.12180. Epub 2016 Jan 21.
引用本文的文献
1
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.单疗程博来霉素、依托泊苷和顺铂（1xBEP）作为睾丸非精原细胞瘤临床1期的辅助治疗：一项基于人群研究的结果、安全性及复发风险因素
Ther Adv Med Oncol. 2022 Mar 31;14:17588359221086813. doi: 10.1177/17588359221086813. eCollection 2022.
本文引用的文献
1
Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer.IV期非小细胞肺癌长期幸存者对临床试验的潜在影响。
JNCI Cancer Spectr. 2019 Jun;3(2):pkz010. doi: 10.1093/jncics/pkz010. Epub 2019 Apr 15.
2
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.KEYNOTE-024 更新分析：PD-L1 肿瘤比例评分≥50%的晚期非小细胞肺癌的帕博利珠单抗对比铂类化疗
J Clin Oncol. 2019 Mar 1;37(7):537-546. doi: 10.1200/JCO.18.00149. Epub 2019 Jan 8.
3
Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001-2016).曲妥珠单抗治疗转移性乳腺癌：澳大利亚全人群队列（2001-2016 年）的真实世界结局。
Breast. 2018 Apr;38:7-13. doi: 10.1016/j.breast.2017.11.007. Epub 2017 Nov 21.
4
More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials.不仅仅是中位数：利用近期随机试验的数据计算HER2阳性转移性乳腺癌患者的生存时间。
Breast. 2017 Feb;31:99-104. doi: 10.1016/j.breast.2016.10.007. Epub 2016 Nov 6.
5
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.晚期胸部恶性肿瘤的分子特征分析与靶向治疗：一项基于生物标志物的多臂、多组织学类型的II期篮式试验。
J Clin Oncol. 2015 Mar 20;33(9):1000-7. doi: 10.1200/JCO.2014.58.2007. Epub 2015 Feb 9.
6
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates.中位数传递信息：基于肿瘤医生估计的生存时间个体化预测的准确性。
J Clin Oncol. 2013 Oct 1;31(28):3565-71. doi: 10.1200/JCO.2012.44.7821. Epub 2013 Sep 3.
7
Survival times of women with metastatic breast cancer starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials.在常规临床实践中开始一线化疗的转移性乳腺癌女性与当代随机试验的生存时间。
Intern Med J. 2013 Aug;43(8):883-8. doi: 10.1111/imj.12178.
8
Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience.使用情景来解释晚期癌症患者的预期寿命：具有癌症经历人群的态度。
Support Care Cancer. 2013 Feb;21(2):369-76. doi: 10.1007/s00520-012-1526-4. Epub 2012 Jun 21.
9
Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials.估算开始接受晚期非小细胞肺癌化疗的患者的典型、最佳和最差预期寿命情景：对当代随机试验的系统评价。
Lung Cancer. 2012 Sep;77(3):537-44. doi: 10.1016/j.lungcan.2012.04.017. Epub 2012 May 18.
10
How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials.我还有多长时间？对转移性乳腺癌一线化疗初治患者的典型、最佳和最差情况进行估算：近期随机试验的系统评价。
J Clin Oncol. 2011 Feb 1;29(4):456-63. doi: 10.1200/JCO.2010.30.2174. Epub 2010 Dec 28.
Zotero 插件